Floatz logo

g17dt

Jaundice

Cancer Advances Inc.Phase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Jaundice cohort.

Asset / SponsorPhaseRating
Lovastatin
Columbia University
Phase 2CC
Photofrin
Samsung Medical Center
N/ANR

Same molecule, other indications

g17dt is also rated in:

pancreatic neoplasmDormant
B
Indicative ·
60 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →